Skip to content
Stop using now Drug recall · FDA · Published December 31, 2018

Aurobindo Pharma Valsartan Tablets Recall: NDEA Impurity Risk

Aurobindo Pharma recalls 320mg Valsartan tablets with NDEA impurity above safe levels. FDA confirmed impurity in API used for manufacturing. Stop using immediately if you have these specific lots.

🇺🇸 FDA recall #D-0370-2019DrugAurobindo Pharma ›
Take action

Contact the company

Recalling firmAurobindo Pharma USA Inc.279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
✎ GovInfoNow plain-language explainer

Aurobindo Pharma is recalling 320mg Valsartan tablets that contain a harmful impurity (NDEA) above safe levels. This impurity could pose a health risk with long-term use, so affected users should stop using the product immediately. Read more at govinfonow.com/recall/39278-aurobindo-pharma-valsartan-tablets-recall-ndea-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39278-aurobindo-pharma-valsartan-tablets-recall-ndea-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0370-2019

Cite this page

“Aurobindo Pharma Valsartan Tablets Recall: NDEA Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39278-aurobindo-pharma-valsartan-tablets-recall-ndea-impurity-risk. Based on FDA recall #D-0370-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0370-2019%22&limit=1).

The FDA announced on Dec. 31, 2018, that Aurobindo Pharma USA Inc. is recalling Valsartan tablets USP 320 mg due to CGMP deviations confirmed by an FDA lab. The agency stated the product contained N-nitrosodimethylamine (NDEA) above the acceptable daily intake level.

How to tell if you have it

  • Brand: Aurobindo Pharma
  • Product: Valsartan tablets USP 320 mg, 90-count bottles, Rx Only
  • NDC: 65862-573-90
  • Lot # VUSD17008-A, exp. date 07/2019
  • Lot # VUSD17009-A, exp. date 09/2019

The hazard

FDA lab testing confirmed the presence of an impurity, N-nitrosodimethylamine (NDEA), in the active pharmaceutical ingredient used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Context

GovInfoNow's records show Aurobindo Pharma USA Inc has had 32 other recalls on record since April 9, 2013. Other recent recalls include Dicyclomine Capsules (July 23, 2026), Acetaminophen Tablets (May 22, 2025), and Nebivolol Tablets (Dec. 6, 2024). Similar recent recalls of other products include Amneal traMADol 50mg Tablets (March 19, 2026), Duloxetine Capsules (April 29, 2026), and Bisoprolol/Hydrochlorothiazide Tablets (Jan. 21, 2026).

How to tell if you have this one

Check for the product name 'Valsartan tablets USP 320 mg, 90-count bottles, Rx Only' with lot numbers VUSD17008-A (exp. 07/2019) or VUSD17009-A (exp. 09/2019).

  • Brand
    Aurobindo Pharma
  • Category
    Drug
FDA recall event · 10 products

All 10 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.
Recall numberProduct, codes & lotsQuantityNDC
D-0361-2019Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-737-30; Lot # VESA17013-A, exp. 10/2019 Lot # VESA17014-A, exp. 10/2019 Lot # VESA18001-A, exp. 12/2019 Lot # VESA18002-A, exp. 12/201918,408 bottles65862-737-30, 65862-737-90, 65862-737-10, 65862-737-03, 65862-739-30, 65862-739-90, 65862-739-10, 65862-739-03, 65862-738-30, 65862-738-90, 65862-738-10, 65862-738-03, 65862-740-30, 65862-740-90, 65862-740-10, 65862-740-03
D-0362-2019Amlodipine and Valsartan Tablets USP 10 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-739-30.; Lot # VFSA17008-A, exp. 10/2019 Lot # VFSA17010-A, exp. 10/2019 Lot # VFSA18002-A, exp. 01/2020 Lot# VFSA18003-A, exp. 01/2020 Lot # VFSA18007-A, exp. 03/2020 Lot # VFSA18008-A, exp. 03/2020 Lot # VKSA17008-A, exp. 05/2019 Lot # VFSA17009-A, exp. 10/2019 Lot # VKSA17014-A, exp. 10/2019 Lot # VKSA17015-A, exp. 10/2019 Lot # VKSA17016-A, exp. 10/2019 Lot # VKSA17017-A, exp. 10/2019 Lot # VKSA18002-A, exp. 01/2020 Lot # VKSA18004-A, exp. 01/202060,417 bottles65862-737-30, 65862-737-90, 65862-737-10, 65862-737-03, 65862-739-30, 65862-739-90, 65862-739-10, 65862-739-03, 65862-738-30, 65862-738-90, 65862-738-10, 65862-738-03, 65862-740-30, 65862-740-90, 65862-740-10, 65862-740-03
D-0363-2019Amlodipine and Valsartan Tablets USP 5 mg/320 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-738-30.; Lot # VMSA17012-A, exp. date 11/2019 Lot # VMSA17013-A, exp. date 11/2019 Lot # VMSA17014-A, exp. date 11/2019 Lot # VMSA17015-A, exp. date 11/2019 Lot # VMSA17016-A, exp. date 11/2019 Lot # VMSA17017-A, exp. date 11/201927,688 bottles65862-737-30, 65862-737-90, 65862-737-10, 65862-737-03, 65862-739-30, 65862-739-90, 65862-739-10, 65862-739-03, 65862-738-30, 65862-738-90, 65862-738-10, 65862-738-03, 65862-740-30, 65862-740-90, 65862-740-10, 65862-740-03
D-0364-2019Amlodipine and Valsartan Tablets USP 10 mg/320 mg. 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-740-30.; Lot # VKSA18005-A, exp. date 03/2020 Lot # VKSA18001-A, exp. date 01/202055,788 bottles65862-737-30, 65862-737-90, 65862-737-10, 65862-737-03, 65862-739-30, 65862-739-90, 65862-739-10, 65862-739-03, 65862-738-30, 65862-738-90, 65862-738-10, 65862-738-03, 65862-740-30, 65862-740-90, 65862-740-10, 65862-740-03
D-0365-2019Valsartan and Hydrochlorothiazide tablets USP 320mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-550-90.; Lot # HRSA17033-A, exp. date 10/2020 Lot # HRSA17034-A, exp. date 10/2020 Lot # HRSA17035-A, exp. date 10/2020 Lot # HRSA17036-A, exp. date 10/2020 Lot # HRSA17037-A, exp. date 10/202023,016 bottles65862-547-90, 65862-547-99, 65862-547-10, 65862-548-90, 65862-548-99, 65862-548-10, 65862-549-90, 65862-549-99, 65862-549-10, 65862-550-90, 65862-550-05, 65862-551-90, 65862-551-05
D-0366-2019Valsartan and Hydrochlorothiazide tablets USP 160mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-548-90.; Lot # HTSA17033-A, exp. date 10/2020 Lot # HTSA17034-A, exp. date 10/2020 Lot # HTSA17035-A, exp. date 10/2020 Lot # HTSA17036-A, exp. date 10/2020 Lot # HTSA17040-A, exp. date 10/2020 Lot # HTSA17041-A, exp. date 11/2020 Lot # HTSA17042-A, exp. date 11/2020 Lot # HTSA17043-A, exp. date 11/2020 Lot # HTSA17037-A, exp. date 10/2020 Lot # HTSA17039-A, exp. date 10/202092,616 bottles65862-547-90, 65862-547-99, 65862-547-10, 65862-548-90, 65862-548-99, 65862-548-10, 65862-549-90, 65862-549-99, 65862-549-10, 65862-550-90, 65862-550-05, 65862-551-90, 65862-551-05
D-0367-2019Valsartan and Hydrochlorothiazide tablets USP 320 mg/25 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-551-90.; Lot # HTSB17049-A, exp. date 08/2020 Lot # HTSB17054-A, exp. date 10/2020 Lot # HTSB17055-A, exp. date 10/2020 Lot # HTSB17056-A, exp. date 10/2020 Lot # HTSB17057-A, exp. date 10/2020 Lot # HTSB17058-A, exp. date 10/2020 Lot # HTSB17059-A, exp. date 10/2020 Lot # HTSB17060-A, exp. date 10/2020 Lot # HTSB17062-A, exp. date 10/2020 Lot # HTSB17066-A, exp. date 10/2020 Lot # HTSB17067-A, exp. date 11/2020 Lot # HTSB17068-A, exp. date 11/2020 Lot # HTSB17069-A, exp. date 11/2020 Lot # HTSB18001-A, exp. date 12/2020 Lot # HTSB18002-A, exp. date 12/2020 Lot # HTSB18003-A, exp. date 12/2020 Lot # HTSB18004-A, exp. date 12/2020 Lot # HTSB18005-A, exp. date 12/2020 Lot # HTSB18006-A, exp. date 12/2020 Lot # HTSB18007-A, exp. date 12/2020 Lot # HTSB17063-A, exp. date 10/2020 Lot # HTSB17064-A, exp. date 10/2020 Lot # HTSB17065-A, exp. date 10/2020 Lot # HTSB18029-A, exp. date 03/2021111,239 bottles65862-547-90, 65862-547-99, 65862-547-10, 65862-548-90, 65862-548-99, 65862-548-10, 65862-549-90, 65862-549-99, 65862-549-10, 65862-550-90, 65862-550-05, 65862-551-90, 65862-551-05
D-0368-2019Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-547-90.; Lot # HVSA17011-A, exp. date 11/2020 Lot # HVSA17012-A, exp. date 11/2020 Lot # HVSA18001-A, exp. date 12/202032,160 bottles65862-547-90, 65862-547-99, 65862-547-10, 65862-548-90, 65862-548-99, 65862-548-10, 65862-549-90, 65862-549-99, 65862-549-10, 65862-550-90, 65862-550-05, 65862-551-90, 65862-551-05
D-0369-2019Valsartan and Hydrochlorothiazide tablets USP 160 mg/25 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-549-90.; Lot # HVSB17023-A, exp. date 08/2020 Lot # HVSB17036-A, exp. date 11/2020 Lot # HVSB17037-A, exp. date 11/2020 Lot # HVSB17038-A, exp. date 11/2020 Lot # HVSB17039-A, exp. date 11/2020 Lot # HVSB17040-B, exp. date 11/2020 Lot # HVSB18001-A, exp. date 12/2020 Lot # HVSB18002-A, exp. date 12/2020 Lot # HVSB18003-A, exp. date 12/2020 Lot # HVSB18004-A, exp. date 12/202053,064 bottles65862-547-90, 65862-547-99, 65862-547-10, 65862-548-90, 65862-548-99, 65862-548-10, 65862-549-90, 65862-549-99, 65862-549-10, 65862-550-90, 65862-550-05, 65862-551-90, 65862-551-05
D-0370-2019Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-573-90.; Lot # VUSD17008-A, exp. date 07/2019 Lot # VUSD17009-A, exp. date 09/201920,604 bottles65862-570-30, 65862-570-99, 65862-570-10, 65862-571-90, 65862-571-99, 65862-571-10, 65862-572-90, 65862-572-99, 65862-572-10, 65862-573-90, 65862-573-05
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    Discontinue use of the recalled Valsartan tablets if you have the specific lot numbers mentioned in the recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 23 days after the firm started it.

1. Firm started the recall: Dec 31, 201812. FDA classified it Class II: Jan 14, 201923. Published in FDA’s Enforcement Report: Jan 23, 2019320182019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have the recalled product?

Stop using the product immediately and contact your doctor for alternative treatment options.

Similar recalls

Other Aurobindo Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0370-2019 (December 31, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0370-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA